Safety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorder

References

• American College of Obstetrics and GynecologyACOG Practice Bulletin Number 15: Premenstrual SyndromeWashington, D.C.American College of Obstetrics and Gynecology2000
   Google Scholar
• MishellDRJrPremenstrual disorders: epidemiology and disease burdenAm J Manag Care20051116 SupplS473S47916336056
   PubMed Web of Science ®Google Scholar
• MortolaJFGirtonLYenSSDepressive episodes in premenstrual syndromeAm J Obstet Gynecol19891616 Pt 1168216872603926
   PubMed Web of Science ®Google Scholar
• MortolaJFGirtonLBeckLYenSSDiagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the calendar of premenstrual experiencesObstet Gynecol19907623023072371035
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders: DSM-IV-Text Revision4th edWashington, DC.American Psychiatric Association2000
   Google Scholar
• JohnsonSRPremenstrual syndrome, premenstrual dysphoric disorder, and beyond: a clinical primer for practitionersObstet Gynecol2004104484585915458909
   PubMed Web of Science ®Google Scholar
• SperoffLFritzMAClinical Gynecologic Endocrinology and Infertility7th edPhiladelphia, PALippincott Williams & Wilkins2005
   Google Scholar
• HalbreichUBorensteinJPearlsteinTKahnLSThe prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD)Psychoneuroendocrinology200328Suppl 3123
   Google Scholar
• MortolaJFPremenstrual syndrome – pathophysiologic considerationsN Engl J Med199833842562579435333
   PubMed Web of Science ®Google Scholar
• SteinerMPearlsteinTPremenstrual dysphoria and the serotonin system: pathophysiology and treatmentJ Clin Psychiatry200061Suppl 12172111041380
   PubMed Web of Science ®Google Scholar
• HalbreichUThe diagnosis of premenstrual syndromes and premenstrual dysphoric disorder–clinical procedures and research perspectivesGynecol Endocrinol200419632033415724807
   PubMed Web of Science ®Google Scholar
• FreemanEWLuteal phase administration of agents for the treatment of premenstrual dysphoric disorderCNS Drugs200418745346815139800
   PubMed Web of Science ®Google Scholar
• RapkinAJYAZ in the treatment of premenstrual dysphoric disorderJ Reprod Med2008539 Suppl72974118980045
   PubMed Web of Science ®Google Scholar
• SchmidtPJNiemanLKDanaceauMAAdamsLFRubinowDRDifferential behavioral effects of gonadal steroids in women with and in those without premenstrual syndromeN Engl J Med199833842092169435325
   PubMed Web of Science ®Google Scholar
• BorensteinJChiouCFDeanBWongJWadeSEstimating direct and indirect costs of premenstrual syndromeJ Occup Environ Med2005471263315643156
   PubMed Web of Science ®Google Scholar
• BorensteinJEDeanBBLeifkeEKornerPYonkersKADifferences in symptom scores and health outcomes in premenstrual syndromeJ Womens Health (Larchmt)20071681139114417937566
   PubMed Web of Science ®Google Scholar
• BorensteinJEDeanBBEndicottJHealth and economic impact of the premenstrual syndromeJ Reprod Med200348751552412953326
   PubMed Web of Science ®Google Scholar
• HylanTRSundellKJudgeRThe impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and FranceJ Womens Health Gend Based Med1999881043105210565662
   PubMed Web of Science ®Google Scholar
• YangMWallensteinGHaganMGuoAChangJKornsteinSBurden of premenstrual dysphoric disorder on health-related quality of lifeJ Womens Health (Larchmt)200817111312118240988
   PubMed Web of Science ®Google Scholar
• RobinsonRLSwindleRWPremenstrual symptom severity: impact on social functioning and treatment-seeking behaviorsJ Womens Health Gend Based Med200099775776811025868
   PubMed Web of Science ®Google Scholar
• LustykMKGerrishWGShaverSKeysSLCognitive-behavioral therapy for premenstrual syndrome and premenstrual dysphoric disorder: a systematic reviewArch Womens Ment Health2009122859619247573
   PubMed Web of Science ®Google Scholar
• BravermanPKPremenstrual syndrome and premenstrual dysphoric disorderJ Pediatr Adolesc Gynecol200720131217289510
   PubMed Web of Science ®Google Scholar
• RapkinAJNew treatment approaches for premenstrual disordersAm J Manag Care20051116 SupplS480S49116336057
   PubMed Web of Science ®Google Scholar
• EmansSLauferMRGoldsteinDPPediatric and Adolescent Gynecology5th edPhildelphia, PALippincott Wiliams & Wilkins2005
   Google Scholar
• FreemanEWSondheimerSJRickelsKGonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled studyPsychopharmacol Bull19973323033099230648
   PubMedGoogle Scholar
• DimmockPWWyattKMJonesPWO’BrienPMEfficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic reviewLancet200035692361131113611030291
   PubMed Web of Science ®Google Scholar
• FreemanEWRickelsKSondheimerSJPolanskyMXiaoSContinuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorderAm J Psychiatry2004161234335114754784
   PubMed Web of Science ®Google Scholar
• FreemanEWSondheimerSJSammelMDFerdousiTLinHA preliminary study of luteal phase versus symptom-onset dosing with escitalopram for premenstrual dysphoric disorderJ Clin Psychiatry200566676977315960573
   PubMed Web of Science ®Google Scholar
• SteinerMSteinbergSStewartDFluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study GroupN Engl J Med199533223152915347739706
   PubMed Web of Science ®Google Scholar
• FreemanEWRickelsKYonkersKAKunzNRMcPhersonMUptonGVVenlafaxine in the treatment of premenstrual dysphoric disorderObstet Gynecol2001985 Pt 173774411704162
   PubMed Web of Science ®Google Scholar
• CohenLSSoaresCNLysterACassanoPBrandesMLeblancGAEfficacy and tolerability of premenstrual use of venlafaxine (flexible dose) in the treatment of premenstrual dysphoric disorderJ Clin Psychopharmacol200424554054315349012
   PubMed Web of Science ®Google Scholar
• Grady-WelikyTAClinical practice. Premenstrual dysphoric disorderN Engl J Med2003348543343812556546
   PubMed Web of Science ®Google Scholar
• FreemanEWRickelsKSondheimerSJPolanskyMA double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndromeJAMA1995274151577791258
   PubMed Web of Science ®Google Scholar
• SmithSRinehartJSRuddockVESchiffITreatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trialObstet Gynecol198770137433299178
   PubMed Web of Science ®Google Scholar
• HarrisonWMEndicottJNeeJTreatment of premenstrual dysphoria with alprazolam. A controlled studyArch Gen Psychiatry19904732702752407209
   PubMed Web of Science ®Google Scholar
• LandenMErikssonOSundbladCAnderschBNaessenTErikssonECompounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placeboPsychopharmacology (Berl)2001155329229811432692
   PubMed Web of Science ®Google Scholar
• WangMHammarbackSLindheBABackstromTTreatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled studyActa Obstet Gynecol Scand199574108038088533564
   PubMed Web of Science ®Google Scholar
• O’BrienPMCravenDSelbyCSymondsEMTreatment of premenstrual syndrome by spironolactoneBr J Obstet Gynaecol1979862142147371663
   PubMedGoogle Scholar
• WyattKDimmockPWO’BrienPMSelective serotonin reuptake inhibitors for premenstrual syndromeCochrane Database Syst Rev20053CD001396
   Google Scholar
• ShahNRJonesJBAperiJShemtovRKarneABorensteinJSelective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysisObstet Gynecol200811151175118218448752
   PubMed Web of Science ®Google Scholar
• JoffeHCohenLSHarlowBLImpact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deteriorationAm J Obstet Gynecol200318961523153014710055
   PubMed Web of Science ®Google Scholar
• AppelTBKambiAABirdsallCA comparison of a new graduated estrogen formulation with three constant-dosed oral contraceptivesContraception19873565235323311619
   PubMed Web of Science ®Google Scholar
• van HeusdenAMFauserBCActivity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptivesContraception199959423724310457868
   PubMed Web of Science ®Google Scholar
• KrattenmacherRDrospirenone: pharmacology and pharmacokinetics of a unique progestogenContraception2000621293811024226
   PubMed Web of Science ®Google Scholar
• RubigADrospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic propertiesClimacteric20036Suppl 3495415018248
   PubMedGoogle Scholar
• ElgerWBeierSPollowKGarfieldRShiSQHillischAConception and pharmacodynamic profile of drospirenoneSteroids20036810–1389190514667981
   PubMed Web of Science ®Google Scholar
• FoidartJMWuttkeWBouwGMGerlingerCHeitheckerRA comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrelEur J Contracept Reprod Health Care20005212413410943575
   PubMedGoogle Scholar
• SangthawanMTaneepanichskulSA comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 microg on premenstrual symptomsContraception20057111715639064
   PubMed Web of Science ®Google Scholar
• SponaJElsteinMFeichtingerWShorter pill-free interval in combined oral contraceptives decreases follicular developmentContraception199654271778842582
   PubMed Web of Science ®Google Scholar
• FreemanEWKrollRRapkinAEvaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorderJ Womens Health Gend Based Med200110656156911559453
   PubMedGoogle Scholar
• PearlsteinTBBachmannGAZacurHAYonkersKATreatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulationContraception200572641442116307962
   PubMed Web of Science ®Google Scholar
• YonkersKABrownCPearlsteinTBFoeghMSampson-LandersCRapkinAEfficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorderObstet Gynecol2005106349250116135578
   PubMed Web of Science ®Google Scholar
• YonkersKANiknianMMarrJPremenstrual dysphoric disorder symptom cluster improvement by cycle with an oral contraceptive (drospirenone 3 mg/ethinyl estradiol 20 micrograms 24/4) (Abstract for poster session at ACOG 56th Annual Clinical Meeting)Obstetrics and Gynecology200811165S
   Web of Science ®Google Scholar
• LopezLMKapteinAHelmerhorstFMOral contraceptives containing drospirenone for premenstrual syndromeCochrane Database Syst Rev20081CD00658618254106
   PubMed Web of Science ®Google Scholar
• BorensteinJYuHTWadeSChiouCFRapkinAEffect of an oral contraceptive containing ethinyl estradiol and drospirenone on premenstrual symptomatology and health-related quality of lifeJ Reprod Med2003482798512621790
   PubMed Web of Science ®Google Scholar
• EndrikatJSandriMGerlingerCRubigASchmidtWFortierMA Canadian multicentre prospective study on the effects of an oral contraceptive containing 3 mg drospirenone and 30 microg ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weightEur J Contracept Reprod Health Care200712322022817763260
   PubMed Web of Science ®Google Scholar
• TaneepanichskulSJaisamrarnUPhupongVEfficacy of Yasmin in premenstrual symptomsArch Gynecol Obstet2007275643343817111156
   PubMedGoogle Scholar
• ApterDBorsosABaumgartnerWEffect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptomsEur J Contracept Reprod Health Care200381375112725674
   PubMed Web of Science ®Google Scholar
• BorgesLEAndradeRPAldrighiJMEffect of a combination of ethinylestradiol 30 microg and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraceptionContraception200674644645017157100
   PubMed Web of Science ®Google Scholar
• BrownCLingFWanJA new monophasic oral contraceptive containing drospirenone. Effect on premenstrual symptomsJ Reprod Med2002471142211838304
   PubMed Web of Science ®Google Scholar
• ParseyKSPongAAn open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogenContraception200061210511110802275
   PubMed Web of Science ®Google Scholar
• HuberJFoidartJMWuttkeWEfficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenoneEur J Contracept Reprod Health Care200051253410836660
   PubMedGoogle Scholar
• ThorneycroftHGollnickHSchellschmidtISuperiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatmentCutis200474212313015379365
   PubMed Web of Science ®Google Scholar
• MaloneyJMDietzePJrWatsonDTreatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trialObstet Gynecol2008112477378118827119
   PubMed Web of Science ®Google Scholar
• KoltunWLuckyAWThiboutotDEfficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trialContraception200877424925618342647
   PubMed Web of Science ®Google Scholar
• PehlivanovBMitkovMEfficacy of an oral contraceptive containing drospirenone in the treatment of women with polycystic ovary syndromeEur J Contracept Reprod Health Care2007121303517455042
   PubMed Web of Science ®Google Scholar
• BatukanCMuderrisIIEfficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutismFertil Steril200685243644016595223
   PubMed Web of Science ®Google Scholar
• FerrimanDGallweyJDClinical assessment of body hair growth in womenJ Clin Endocrinol Metab1961211440144713892577
   PubMed Web of Science ®Google Scholar
• BachmannGSulakPJSampson-LandersCBendaNMarrJEfficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenoneContraception200470319119815325887
   PubMed Web of Science ®Google Scholar
• OelkersWFoidartJMDombroviczNWelterAHeitheckerREffects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolismJ Clin Endocrinol Metab1995806181618217775629
   PubMed Web of Science ®Google Scholar
• FoidartJMThe contraceptive profile of a new oral contraceptive with antimineralocorticoid and antiandrogenic effectsEur J Contracept Reprod Health Care20005Suppl 32533
   Google Scholar
• FoidartJMAdded benefits of drospirenone for complianceClimacteric20058Suppl 3283416203653
   PubMed Web of Science ®Google Scholar
• Bayer HealthCare PharmaceuticalsYAZ combination brief and detailed patient labeling (package insert)Wayne, NJBayer HealthCare Pharmaceuticals, Inc200718
   Google Scholar
• SchürmannRBlodeHBendaNCroninMKufnerAEffect of drospirenone on serum potassium and drospirenone pharmacokinetics in women with normal or impaired renal functionJ Clin Pharmacol200646886787516855071
   PubMed Web of Science ®Google Scholar
• SchüttBKunzMBlodeHCoadministration of estradiol/drospirenone and indomethacin does not cause hyperkalemia in healthy postmenopausal women: a randomized open-label crossover studyJ Clin Pharmacol200747677478117463217
   PubMed Web of Science ®Google Scholar
• DingerJCHeinemannLAKuhl-HabichDThe safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142, 475 women-years of observationContraception200775534435417434015
   PubMed Web of Science ®Google Scholar
• SeegerJDLoughlinJEngPMCliffordCRCutoneJWalkerAMRisk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptivesObstet Gynecol2007110358759317766604
   PubMed Web of Science ®Google Scholar
• GaspardUScheenAEndrikatJA randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolismContraception200367642342912814810
   PubMed Web of Science ®Google Scholar
• KlippingCMarrJEffects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospire-none or desogestrel on lipids, hemostatic parameters and carbohydrate metabolismContraception200571640941615914128
   PubMed Web of Science ®Google Scholar